Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Patheon Announces Leadership Change

December 2, 2010 6:53 am | News | Comments

Patheon announced that Wesley P. Wheeler, the company's chief executive officer and president, has left the company. Peter Bigelow has been named interim chief executive officer.


Harvard Bioscience Licenses Cellectis Electroporation Instruments

December 2, 2010 6:47 am | News | Comments

Cellectis and Harvard Apparatus signed a license agreement that grants Harvard Apparatus the worldwide exclusive right to manufacture and sell, for research use, a line of electroporation-based instruments.


FDA Panel Rejects Drugs to Prevent Prostate Cancer

December 2, 2010 6:42 am | by Matthew Perrone, AP Health Writer | News | Comments

A panel of federal health experts rejected the use of two drugs from Merck and GlaxoSmithKline to prevent prostate cancer, saying the drugs could actually raise the risk of the most serious types of tumors.


Momenta Sues Teva for Patent Infringement

December 2, 2010 6:38 am | News | Comments

Momenta Pharmaceuticals, Inc. announced that it has sued Teva Pharmaceutical Industries Ltd. in the United States District Court for the District of Massachusetts for infringement of two Momenta patents.


Cancer Drugs Offer Hope for Crohn’s Disease and Sarcoidosis

December 2, 2010 6:35 am | News | Comments

A new finding offers insight into a new treatment avenue for two painful inflammatory diseases: Crohn’s Disease and sarcoidosis.


FDA Wants More Data on Valeant-Glaxo Epilepsy Drug

December 2, 2010 6:31 am | News | Comments

Valeant Pharmaceuticals International Inc. and GlaxoSmithKline PLC said that the Food and Drug Administration (FDA) did not approve their epilepsy drug candidate ezogabine.


Pfizer Gets New European Approval for Sutent

December 2, 2010 6:28 am | News | Comments

Drug developer Pfizer Inc. said December 2 it received European regulatory approval for Sutent as a treatment for a rare type of pancreatic tumors.


FDA Clears Clinical Trials for Alzheimer's Compound

December 2, 2010 6:22 am | News | Comments

QR Pharma, Inc. announced that the FDA has accepted the Investigational New Drug application to begin human clinical trials and evaluate the safety and efficacy of the company’s second product, bisnorcymserine (BNC).


First European Marketing Approval for SUMAVEL DosePro

December 2, 2010 6:19 am | News | Comments

Zogenix, Inc. and Desitin Pharmaceuticals GmbH announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application for SUMAVEL DosePro Needle-Free Delivery System.


Structural Prediction Software

December 1, 2010 8:21 am | Product Releases | Comments

Integrated DNA Technologies, a leader in oligonucleotide synthesis, and Rensselaer Polytechnic Institute announced the launch of the UNAFold secondary structure prediction software at IDT.


RAR-gamma Screening Kit

December 1, 2010 8:18 am | Product Releases | Comments

A robust, off-the-shelf solution for screening Human Retinoic Acid Receptor Gamma (RAR?) is now available from INDIGO Biosciences. INDIGO Nuclear Receptor Assay Kits go from freezer to data in 24 hours with minimal hands-on time.


Guide to Good Washing Practice

December 1, 2010 8:11 am | News | Comments

Thermo Fisher Scientific Inc. offers a ‘guide to good washing practice,’ an online guide is designed as a step-by-step tool, providing detailed guidance on obtaining secure and reliable performance with every use of the its Wellwash microplate washers.


HCS Plates

December 1, 2010 8:08 am | Drug Discovery & Development | Product Releases | Comments

CYTOO Cell Architects introduced CYTOOplates 96 for pharma, biotech and academic screening center customers employing high content cell-based assays for research, drug safety, and drug screening applications.


Aushon Partners with LightArray in China

December 1, 2010 8:06 am | News | Comments

Aushon BioSystems, Inc. has partnered with LightArray Biotech Company, Ltd., to provide Aushon’s suite of multiplex biomarker products and services to pharmaceutical, biotechnical, and academic research institutions located in mainland China.


Advanced Clinical Hires New VP

December 1, 2010 8:00 am | News | Comments

Advanced Clinical, a leader in pharmaceutical development, announced an addition to its leadership team: Mark Lanfear has been hired as Vice President, Clinical Operations to lead Advanced Clinical in its expansion of service offerings for 2011.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.